Home Cancer Gastric Cancer

Gastric Cancer

    Random
    Gastric Cancer

    EC Approves Three-Year Treatment Label Update for Novartis’ Glivec

    Gastric Cancer

    Epigenetics Study Identifies Gastric Cancer Subtype

    Gastric Cancer

    FDA Approves Label Change Recommending Three Years of Novartis’ Glivec After...

    Gastric Cancer

    Janssen to Develop Bispecific Antibodies Based on Zymeworks Platforms in Up-to-$1.4B...

    Gastric Cancer

    BioNTech Boosting Pipeline, Manufacturing, Global Presence with $325M in Series B...

    Gastric Cancer

    Sumitomo Dainippon Cancer Stemness Inhibitor Napabucasin Disappoints in Phase III

    Gastric Cancer

    BMS and Aslan Establish Deal for Early Clinical-Stage Anticancer cMET Inhibitor

    Gastric Cancer

    Roche Cancer Vaccine Pact Could Net Immatics $1B-Plus

    data
    Gastric Cancer

    Machine Learning Predicts Therapeutic Response in Gastric Cancer

    Gastric Cancer

    Roche’s Kadcyla Fails Phase II/III Trial for Gastric Cancer

    123Page 1 of 3
    Copyright © 2022 Genetic Engineering & Biotechnology News. All Rights Reserved.